Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 2
1999 2
2000 3
2001 2
2002 9
2003 13
2004 31
2005 34
2006 41
2007 47
2008 50
2009 60
2010 79
2011 78
2012 87
2013 90
2014 87
2015 74
2016 74
2017 97
2018 90
2019 70
2020 95
2021 69
2022 59
2023 53
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

1,212 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
Gupta AK, Talukder M, Williams G. Gupta AK, et al. J Dermatolog Treat. 2022 Nov;33(7):2946-2962. doi: 10.1080/09546634.2022.2109567. Epub 2022 Aug 15. J Dermatolog Treat. 2022. PMID: 35920739 Review.
Recently, Japan and South Korea have approved oral dutasteride (0.5 mg/d) for male AGA. EFFICACY AND SAFETY: A probable efficacy ranking, in decreasing order, is - dutasteride 0.5 mg/d, finasteride 5 mg/d, minoxidil 5 mg/d, finasteride 1 mg/d, followed by minoxidil …
Recently, Japan and South Korea have approved oral dutasteride (0.5 mg/d) for male AGA. EFFICACY AND SAFETY: A probable efficacy rank …
Dutasteride in Androgenetic Alopecia: An Update.
Arif T, Dorjay K, Adil M, Sami M. Arif T, et al. Curr Clin Pharmacol. 2017;12(1):31-35. doi: 10.2174/1574884712666170310111125. Curr Clin Pharmacol. 2017. PMID: 28294070 Review.
In this review, after the pharmacology of dutasteride, the authors have discussed the status of dutasteride in androgenetic alopecia and have compared its efficacy with that of finasteride. ...Therefore, dutasteride could become a treatment of choice for AGA …
In this review, after the pharmacology of dutasteride, the authors have discussed the status of dutasteride in androgenetic al …
Sexual side effects of 5-alpha-reductase inhibitors finasteride and dutasteride: A comprehensive review.
Fertig RM, Gamret AC, Darwin E, Gaudi S. Fertig RM, et al. Dermatol Online J. 2017 Nov 11;23(11):13030/qt24k8q743. Dermatol Online J. 2017. PMID: 29447628 Free article. Review.
The 5-alpha-reductase inhibitors finasteride and dutasteride are frequently used in the treatment of androgenetic alopecia and benign prostatichyperplasia. ...This review is an extensive look at the sexual effects of 5-alpha-reductase inhibitors and compares outcomes for f …
The 5-alpha-reductase inhibitors finasteride and dutasteride are frequently used in the treatment of androgenetic alopecia and benign …
Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice.
Saceda-Corralo D, Moustafa F, Moreno-Arrones Ó, Jaén-Olasolo P, Vañó-Galván S, Camacho F. Saceda-Corralo D, et al. J Drugs Dermatol. 2022 Jul 1;21(7):742-747. doi: 10.36849/JDD.6610. J Drugs Dermatol. 2022. PMID: 35816059
OBJECTIVE: The main objective was to describe the safety profile of mesotherapy with dutasteride in real clinical practice in a large cohort of patients with androgenetic alopecia. ...No serious or sexual adverse events were detected. CONCLUSION: Mesotherapy with dutast
OBJECTIVE: The main objective was to describe the safety profile of mesotherapy with dutasteride in real clinical practice in a large …
Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study.
Sánchez-Meza E, Ocampo-Candiani J, Gómez-Flores M, Herz-Ruelas ME, Ocampo-Garza J, Orizaga-Y-Quiroga TL, Martínez-Moreno A, Ocampo-Garza SS. Sánchez-Meza E, et al. J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e806-e808. doi: 10.1111/jdv.18285. Epub 2022 Jun 16. J Eur Acad Dermatol Venereol. 2022. PMID: 35648446 Clinical Trial. No abstract available.
Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
Lee S, Lee YB, Choe SJ, Lee WS. Lee S, et al. Acta Derm Venereol. 2019 Jan 1;99(1):12-17. doi: 10.2340/00015555-3035. Acta Derm Venereol. 2019. PMID: 30206635 Free article.
The relative risk was 1.66 (95% CI 1.20-2.30) for finasteride and 1.37 (95% CI 0.81-2.32) for dutasteride. Both drugs were associated with an increased risk, although the increase was not statistically significant for dutasteride. As studies into dutasteride
The relative risk was 1.66 (95% CI 1.20-2.30) for finasteride and 1.37 (95% CI 0.81-2.32) for dutasteride. Both drugs were associated …
Dutasteride.
Evans HC, Goa KL. Evans HC, et al. Drugs Aging. 2003;20(12):905-16; discussion 917-8. doi: 10.2165/00002512-200320120-00005. Drugs Aging. 2003. PMID: 14565784 Review.
Dutasteride, a potent inhibitor of type 1 and 2 5alpha-reductase, reduced dihydrotestosterone levels by >90% in 85% of patients following 1 years' administration of oral dutasteride 0.5 mg/day. ...Dutasteride was generally well tolerated. Impotence, reduce
Dutasteride, a potent inhibitor of type 1 and 2 5alpha-reductase, reduced dihydrotestosterone levels by >90% in 85% of patients fo
Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
Shanshanwal SJ, Dhurat RS. Shanshanwal SJ, et al. Indian J Dermatol Venereol Leprol. 2017 Jan-Feb;83(1):47-54. doi: 10.4103/0378-6323.188652. Indian J Dermatol Venereol Leprol. 2017. PMID: 27549867 Free article. Clinical Trial.
Dutasteride inhibits both type I and type II 5-alpha-reductase while finasteride inhibits only the type II enzyme. As both isoenzymes are present in hair follicles, it is likely that dutasteride is more effective than finasteride. AIMS: To compare the efficacy, safe
Dutasteride inhibits both type I and type II 5-alpha-reductase while finasteride inhibits only the type II enzyme. As both isoenzymes
1,212 results